Trade Summary

6 days ago, Kaplan Johanne, serving as Chief Development Officer at ProMIS Neurosciences Inc. (PMN), purchased 2,280 shares at $13.30 per share, for a total transaction value of $30,324.00. Following this transaction, Kaplan Johanne now holds 6,221 shares of PMN.

This purchase represents a 57.85% increase in Kaplan Johanne's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 4:00 PM ET, 2 days after the trade was made.

ProMIS Neurosciences Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.